Viridian Therapeutics, Inc./DE Operating Lease, Liability, Current
Viridian Therapeutics, Inc./DE (VRDN) had Operating Lease, Liability, Current of $722.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Current $722.00K.
- 2026-03-31: Operating Lease, Liability, Current $738.00K.
- 2025-12-31: Operating Lease, Liability, Current $753.00K.
- 2025-09-30: Operating Lease, Liability, Current $730.00K.
| Period end | Operating Lease, Liability, Current | Operating Lease, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $722.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $738.00K 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $753.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $730.00K 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $553.00K 10-Q · filed 2025-08-06 | |
| 2025-03-31 | $536.00K 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $513.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $589.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $507.00K 10-Q · filed 2024-08-08 | |
| 2024-04-30 | $1.90M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $732.00K 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $843.00K 10-K · filed 2025-03-03 | |
| 2023-09-30 | $821.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $802.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $637.00K 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $613.00K 10-K · filed 2024-02-27 | |
| 2022-09-30 | $564.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $580.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $579.00K 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $520.00K 10-K · filed 2023-03-09 | |
| 2021-09-30 | $430.00K 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $412.00K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.60M 10-Q · filed 2024-08-08 | $355.00K 10-Q · filed 2021-05-07 |
| 2020-12-31 | $455.00K 10-K · filed 2022-03-11 | |
| 2020-10-31 | $100.00K 10-Q · filed 2024-08-08 | |
| 2020-01-01 | $1.60M 10-Q · filed 2021-11-05 | $400.00K 10-K · filed 2021-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |